TY - JOUR T1 - Presentation of new onset anosmia during the COVID-19 pandemic. AU - Hopkins,C, AU - Surda,P, AU - Kumar,N, PY - 2020/4/12/pubmed PY - 2020/6/10/medline PY - 2020/4/12/entrez SP - 295 EP - 298 JF - Rhinology JO - Rhinology VL - 58 IS - 3 N2 - INTRODUCTION: Anosmia has not been formally recognised as a symptom of COVID-19 infection. Growing anecdotal evidence suggests increasing incidence of cases of anosmia during the current pandemic, suggesting that COVID-19 may cause olfactory dysfunction. The objective was to characterise patients reporting new onset anosmia during the COVID-19 pandemic METHODOLOGY: Design: Survey of 2428 patients reporting new onset anosmia during the COVID-19 pandemic. SETTING: Volunteer sample of patients seeking medical advice of recent onset self-diagnosed loss of sense of smell RESULTS: 2428 surveys were completed within 7 days; 64% respondents were under 40. The majority of respondents reported onset of their anosmia in the last week. Of the cohort, 17% did not report any other symptom thought to be associated with COVID-19. In patients who reported other symptoms, 51% reported either cough or fever and therefore met current guidelines for self-isolation. CONCLUSIONS: Anosmia is reported in conjunction with well-reported symptoms of coronas virus, but 1 in 6 patients with recent onset anosmia report this as an isolated symptom. This might help identify otherwise asymptomatic carriers of disease and trigger targeted testing. Further study with COVID-19 testing is required to identify the proportion of patients in whom new onset anosmia can be attributed to COVID-19. SN - 0300-0729 UR - https://www.unboundmedicine.com/medline/citation/32277751/Presentation_of_new_onset_anosmia_during_the_COVID_19_pandemic_ DB - PRIME DP - Unbound Medicine ER -